Pregnancy seems to increase the risk of mental illness among women with multiple sclerosis. Pregnant MS patients have a higher risk of mental illness during gestation and in the first years after they ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

PHOENIX — Two new datasets support the use of potent disease-modifying therapies (DMTs) during pregnancy in women with active multiple sclerosis (MS), reinforcing a growing shift toward treatment when ...

—A large international team of experts examined relapse activity and disability progression among pregnant and nonpregnant women of reproductive age with moderate-to-severe multiple sclerosis (MS).

New data on the use of natalizumab (Tysabri, Biogen) during pregnancy in women with multiple sclerosis (MS) have shown that continued use of the drug is associated with a lower risk of relapses during ...

LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology — For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During the XXIV ...

An analysis of over 3,700 pregnancies of women with multiple sclerosis indicates that the therapy doesn’t lead to increased risks of miscarriage, premature birth or serious birth defects. Many women ...

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a ...

Many women with multiple sclerosis remained untreated before conception, during pregnancy, and postpartum, though preconception and postpartum ocrelizumab use increased between 2019 and 2023. Nearly ...

The data for the pregnancies included in the study came from the German Multiple Sclerosis and Pregnancy Registry and was collected between November 2006 and June 2023. 2,885 pregnancies were analyzed ...